Aratana Therapeutics, Inc. Operating Income 2013-2019 | PETX
Aratana Therapeutics, Inc. operating income from 2013 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Aratana Therapeutics, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2018 | $-12 |
| 2017 | $-44 |
| 2016 | $-31 |
| 2015 | $-89 |
| 2014 | $-42 |
| 2013 | $-20 |
| 2012 | $-12 |
| 2011 | $-3 |
| Aratana Therapeutics, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2019-03-31 | $-7 |
| 2018-12-31 | $-8 |
| 2018-09-30 | $9 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-15 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $-10 |
| 2017-03-31 | $-12 |
| 2016-12-31 | $-23 |
| 2016-09-30 | $-13 |
| 2016-06-30 | $22 |
| 2016-03-31 | $-17 |
| 2015-12-31 | $-12 |
| 2015-09-30 | $-55 |
| 2015-06-30 | $-11 |
| 2015-03-31 | $-11 |
| 2014-12-31 | $-12 |
| 2014-09-30 | $-11 |
| 2014-06-30 | $-10 |
| 2014-03-31 | $-9 |
| 2013-12-31 | $-8 |
| 2013-09-30 | $-5 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-3 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-3 |
